GlassScriptPhysician profile
Danielle Marie Giesler
NPI 1710298328
$15,539.11
in general payments reported to CMS, 2019-2025
27 companies · $4,382 in 2025
The $4,382 reported for 2025 was more than what 87% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $24.24 · 2021: $4,231 · 2022: $4,652 · 2023: $1,299 · 2024: $131 · 2025: $4,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $1,035 · Travel and Lodging: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $1,034.87 |
| Travel and Lodging | $776.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,900.29 | 2019-2025 | |
| Thd America, INC. | $994.15 | 2022-2025 | |
| Axonics, INC. | $356.69 | 2020-2024 | Axonics |
| Sirtex Medical INC | $251.59 | 2019-2022 | |
| Davol INC. | $179.37 | 2019-2023 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $153.95 | 2023-2025 | Codman Hakim, Codman Certas, Cusa Clarity |
| Takeda Pharmaceuticals U.S.A., INC. | $105.04 | 2023-2025 | Gattex |
| Allergan, INC. | $86.43 | 2019 | |
| Philips North America LLC | $84.38 | 2025 | Azurion 5 M20 |
| Medtronic, INC. | $52.61 | 2023-2025 | Signia |
| Tela Bio, INC. | $50.16 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $45.45 | 2019 | |
| Coloplast Corp | $33.00 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $30.47 | 2019 | |
| Acacia Pharma INC | $26.81 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $22.84 | 2021 | |
| Activ Surgical, INC. | $20.17 | 2022 | |
| Mimedx Group, INC. | $19.65 | 2025 | |
| Baxter Healthcare | $16.48 | 2025 | Perclot |
| Ethicon US, LLC | $16.14 | 2019 | |
| Abbvie INC. | $15.77 | 2023 | |
| Trevena, INC. | $15.39 | 2021 | |
| Myriad Genetic Laboratories, INC. | $14.88 | 2023 | Myrisk |
| Levita Magnetics International Corp | $13.34 | 2019 | |
| Convatec INC. | $11.70 | 2020 | |
| Cook Medical LLC | $11.24 | 2019 | |
| Zyla Life Sciences, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Giesler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.